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Integrative inference of subclonal tumour evolution
from single-cell and bulk sequencing data
Salem Malikic1,2,6, Katharina Jahn3,4,6, Jack Kuipers3,4,6, S. Cenk Sahinalp5,7 & Niko Beerenwinkel 3,4,7
Understanding the clonal architecture and evolutionary history of a tumour poses one of the
key challenges to overcome treatment failure due to resistant cell populations. Previously,
studies on subclonal tumour evolution have been primarily based on bulk sequencing and in
some recent cases on single-cell sequencing data. Either data type alone has shortcomings
with regard to this task, but methods integrating both data types have been lacking. Here,
we present B-SCITE, the ﬁrst computational approach that infers tumour phylogenies from
combined single-cell and bulk sequencing data. Using a comprehensive set of simulated data,
we show that B-SCITE systematically outperforms existing methods with respect to tree
reconstruction accuracy and subclone identiﬁcation. B-SCITE provides high-ﬁdelity recon-
structions even with a modest number of single cells and in cases where bulk allele fre-
quencies are affected by copy number changes. On real tumour data, B-SCITE generated
mutation histories show high concordance with expert generated trees.
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Cancer is a genetic disease that develops through a branchedevolutionary process1. It is characterised by the emergenceof genetically distinct subclones through the random
acquisition of mutations at the level of single cells and shifting
prevalences at the subclone level through selective advantages
purveyed by driver mutations. This interplay creates complex
mixtures of tumour-cell populations, which exhibit different
susceptibilities to targeted cancer therapies and are suspected to
be the cause of treatment failure2,3. Therefore, it is of great
interest to obtain a better understanding of the evolutionary
histories of individual tumours and their subclonal composition4.
Most genetic analyses of tumours are currently based on next-
generation sequencing data of bulk tumour samples. Such data
provide indirect measurements of the subclonal tumour compo-
sition in the form of aggregate total and variant read counts
measured across hundreds of thousands or millions of cells. A
large number of approaches have been published over the last
few years that try to identify subclones, their frequencies and in
some cases, their phylogenetic relationships by deconvolving
these aggregate data5–23. However, the underlying statistical
problem is underdetermined24,25, and single-nucleotide variants
(SNVs) with similar variant allele frequencies (VAFs) are auto-
matically clustered into a single subclone. This inevitably leads to
incorrect phylogenies for tumours with multiple distinct sub-
clones of similar prevalences as illustrated in Fig. 1. The aggregate
sequencing data additionally pose a limitation to the achievable
tree resolution, as mutational signals of smaller subclones cannot
be distinguished from noise26 and therefore not be reliably
represented in the tree. Sequencing multiple samples from the
same tumour and increasing the coverage can to some extent
mitigate these issues, but is not always practicable.
Another solution is the use of single-cell sequencing (SCS) data
which provide mutation proﬁles of individual cells, such that the
phylogeny can be directly inferred without any form of decon-
volution. The main challenge here instead are the high levels
of noise found in SCS data that are primarily introduced during
DNA ampliﬁcation, a necessary step to obtain sufﬁcient DNA
material for sequencing. False negatives are the most prevalent
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Fig. 1 Comparison of inferred mutation histories based on single-cell and bulk-sequencing data. a Ground truth clonal tree with mutations M1, …, M10: the
coloured nodes represent the subclones, and the tree structure indicates the partial temporal order in which the subclones emerged (from top to bottom).
Each subclone contains the mutations it acquired in comparison with its parent and is annotated with the mean VAF of these mutations. (For a
heterozygous mutation in a copy-number-neutral region, the VAF is half the mutation’s cellular prevalence.) b Cell mutation proﬁles obtained from the SCS
data for nine cells c1, …, c9: ‘1’ indicates the observed presence of a mutation, and ‘0’ absence. A ‘?’ indicates a missing data point (NA), e.g., due to
insufﬁcient coverage. The red ‘0’s are false negatives (e.g., drop-out events), the red ‘1’ indicates a false positive. Due to these errors, the mutation matrix
deﬁnes no perfect phylogeny. c Inferred single-cell mutation tree annotated with single-cell placements. Not all cells can be placed, such that their observed
mutation proﬁle matches with the mutations acquired along the lineage from the root to their attachment point. The branching point of the ground truth
tree is inferred correctly, due to the strong signal that the red/orange and blue/green mutations do not occur in the same cell. However, mutation order in
linear segments is not reliably inferred from the SCS data; especially in the right branch, a mutation with low prevalence (M10) is placed above a more
prevalent mutation (M9) due to errors in the mutation proﬁles of cells c6, c7 and c9. d Variant allele frequencies obtained from bulk sequencing. VAF-based
clustering of mutations leads to merging of subclones. e, f Both clonal trees are compatible with the VAFs and the clustering inferred in (d). Due to the
clustering and incompatible VAFs, the correct branching between the blue and red subclone is not inferred, but in both trees, mutation ordering is
consistent with their true prevalences
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error type due to allelic dropout, but also false positives occur
when an error is introduced early in the ampliﬁcation. Further
noise stems from doublet-mutation proﬁles, which occur when
two cells are accidentally sequenced together27. Classic approa-
ches for phylogeny reconstruction are not suitable for dealing
with these SCS-speciﬁc noise proﬁles, and a number of prob-
abilistic approaches have been developed to speciﬁcally account
for the error types found in SCS data28–32.
A major difference between the evolutionary histories of tumours
inferred from bulk and SCS data is that the former typically are
clonal trees where mutations with similar frequencies are clustered
together and represented in a single tree node (Fig. 1e, f), while
trees derived from SCS data are fully resolved trees that can be
either cell lineage trees, binary trees where the cells form the leaves
and mutations occur along tree branches, or mutation trees (Fig. 1c)
that depict the partial temporal order in which mutations were
acquired33. For cell lineage trees, a heuristic has been proposed for
clustering cells into clones in a post-processing step29, which results
in trees that are closer to bulk clonal trees.
Another difference, as illustrated in Fig. 1, is that the VAFs
obtained from a bulk sample are well suited for inferring the
temporal order of mutations (by ordering mutations with respect
to decreasing VAF), but of limited use for the identiﬁcation of
branching events. On the contrary, single-cell genotypes obtained
from SCS data have a lot of strength to infer branching events,
but due to unobserved ancestral states and high noise levels, may
give ambiguous or no signals on the temporal order of mutations
in linear segments of the inferred mutation trees.
As the strengths and weaknesses of single-cell and bulk-
sequencing data are to a large extent complementary with respect
to phylogeny inference, using both data types for a joint inference
should improve our understanding of subclonal tumour evolution
over using each type of data alone. It has already been shown that
clustering of mutations into subclones from bulk-sequencing data
can be informed by single-cell genotypes to obtain more accurate
results34. In this work, we present B-SCITE, a probabilistic
approach for the inference of tumour phylogenies from combined
single-cell and bulk-sequencing data. We show in a comprehen-
sive simulation study that B-SCITE systematically outperforms
competing approaches in terms of accurate tree reconstruction
and mutation clustering. It performs particularly well in difﬁcult
cases, where only a small number of single cells is available, or
when bulk read counts are affected by copy-number changes.
We also show that for real tumour data, B-SCITE provides
mutation histories that are in better congruence with expert-
generated trees than tools relying only on a single data type.
Results
Method overview. We developed B-SCITE, a probabilistic
approach for the inference of tumour mutation histories by the
use of SNV data obtained from single-cell and bulk DNA
sequencing (Fig. 2). Full technical details are given in the
‘Methods’ section. B-SCITE consists of a Markov chain Monte
Carlo-based search scheme to traverse the space of possible tree
topologies and a joint likelihood model for the evaluation of
candidate trees based on their joint ﬁt to the single-cell and bulk
data. The single-cell data are given in the form of a mutation
matrix, where each row represents a mutation, for which each
column represents that mutation’s state in the corresponding
single cell (‘0’ normal state, ‘1’ altered state and ‘NA’ missing
data); on the other hand, the bulk data consist of the variant
and total read counts of the mutated loci in each of the sequenced
bulk samples. B-SCITE reports a single maximum likelihood
mutation tree that can be condensed into a clonal tree by clus-
tering linear tree segments based on VAF similarity.
Performance assessment on simulated data. We tested B-SCITE
on a comprehensive set of simulated data. We focused initially
on comparing with ddClone34, which is, to the best of our
knowledge, the only existing method that performs analysis of
intra-tumour heterogeneity by jointly using bulk and SCS data.
ddClone was shown to signiﬁcantly outperform methods only
utilising the bulk-sequencing data. For ease of comparison,
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Fig. 2 B-SCITE uses a Markov chain Monte Carlo approach to search the space of candidate mutation histories. Each candidate tree is scored based on its
joint ﬁt to the single-cell and bulk DNA sequencing data. The bulk data consist of a high-coverage variant and total read counts for the mutated loci. The
single-cell data consist of the observed mutation proﬁles of the sequenced cells. These single-cell proﬁles are characterised by high noise rates (θ) that are
learned from the SCS data along with the tree topology T. B-SCITE reports the tree with the highest joint score. This tree is a fully resolved mutation tree.
To obtain a clonal tree, the linear tree parts can be clustered based on the variant allele frequencies of the bulk data
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we followed the simulation strategy employed in the original
ddClone publication (see Supplementary Methods for details).
Since B-SCITE infers tumour phylogenies, we additionally
compared against the two tree inference methods, OncoNEM29
and SCITE28, which are working on single-cell data only.
All box plots used for presenting performance of the methods
on the simulated data were generated using ggplot235, with its
default settings and the data points overlaid.
Comparisons of clustering accuracy. Since ddClone does not
provide any output related to the tree of tumour evolution, we
used the V-measure of cluster assignments36 and adjusted Rand
index of cluster assignments in our comparisons. For B-SCITE,
the clonal tree derived from the fully resolved maximum like-
lihood tree provides the mutation clusters. Namely, each clone C
deﬁnes a unique cluster consisting of all mutations appearing
for the ﬁrst time at C. OncoNEM also provides an option to
cluster the data into subclones based on the inferred phylogeny,
and is hence included in the comparison.
The results on simulations (Fig. 3 for 25 single cells and 10
clones) show that B-SCITE consistently outperforms both
ddClone and OncoNEM. B-SCITE and ddClone are both robust
to doublet contamination and distortion in the single-cell data
sampling denoted by λ. The latter introduces a discrepancy
between the genotype frequencies of the sequenced single cells
and the subclone frequencies of the bulk tumour tissue, where
larger values of λ indicate better agreement between the
frequencies (for more details see Supplementary Methods).
OncoNEM, which only utilises single-cell data, improves as the
sampling of single cells more closely reﬂects the bulk tumour
composition (as λ increases). Even for highly distorted data,
OncoNEM performs a little better than ddClone. However, when
simulating a smaller number of clones (Supplementary Fig. 1 with
six clones instead of ten), the gap between OncoNEM and
ddClone increases while B-SCITE remains the best performer.
Increasing the number of cells from 25 to 50 and 100 has a
marginal effect on the accuracy with 10 clones (Supplementary
Fig. 2, although more of the simulated clones may also be observed
with more cells). As the number of clones increases (Supplementary
Figs. 3, 4), OncoNEM’s performance decreases although it is aided
by larger cell numbers, while ddClone’s performance starts to
degrade, as more cells allow more of the simulated clones to be
observed. B-SCITE retains the best and most stable performance. A
similar pattern is seen when computing the accuracy with the
adjusted Rand index (Supplementary Figs. 5–7), which ampliﬁes the
differences between the methods.
The effect of allelic dropout and false negatives is relatively
mild on B-SCITE (Supplementary Fig. 8) and has a more
noticeable effect on ddClone and OncoNEM. A similar
dependence on false negatives is seen with a highly elevated
false-positive rate (Supplementary Fig. 9), and the false positives
lead to a small but clear decrease in accuracy for B-SCITE.
OncoNEM also suffers a slight loss in accuracy, while ddClone
actually improves marginally with the higher error rate though
still with the worst performance overall.
Accuracy in inferring phylogenetic order of mutations. In
addition to clustering mutations into subclones, B-SCITE also
infers the complete phylogenetic history of a tumour. We there-
fore compared B-SCITE with the single-cell phylogenetic meth-
ods OncoNEM and SCITE based on three different accuracy
measures (the deﬁnition of each measure is available in the Sup-
plementary Methods). Speciﬁcally, for SCITE, we chose the
extended version with the doublet model27 to make sure that any
change in performance can be fully attributed to the additional
data available to B-SCITE.
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Fig. 3 Accuracy of mutation clustering by ddClone, OncoNEM and B-SCITE for 100 simulated clonal trees with 10 nodes (clones) and 50 mutations. For the
single-cell data, we drew 25 genotypes from each clonal tree for various values of parameter λ, which controls bias in sampling single cells from clones
(large values of λ indicate a small bias, where the probability of drawing a single cell from a given clone is usually close to its prevalence in the entire
tumour cell population). We also added the following noise to the single-cell genotypes: false-positive rate 10−5, false-negative rate 0.2, missing (NA) rate
0.05 and doublet rates 0, 0.1 and 0.2. Bulk data coverage was set to 10,000, and variant read counts drawn from a binomial distribution. We obtained data
sets from trees for each parameter combination. A more detailed description of the simulation data is given in Supplementary Methods. For the deﬁnition
of V-measure see ref. 36. Source data are provided as a Source Data ﬁle
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B-SCITE again has the best and most robust performance over
the range of λ (Fig. 4). The two single-cell methods improve, as
the single-cell sampling approaches a better representation of the
bulk frequencies, but never reaches the performance of B-SCITE.
The apparent improvement for B-SCITE as λ decreases is due
to the smaller number of observed clones being included in the
calculation of the tree accuracy.
Changing the number of clones or cells (Supplementary
Figs. 10–13), we observe the same pattern with B-SCITE on
top, and SCITE performing slightly better than OncoNEM.
Similar behaviour is also observed for inferring the correct
ancestry relationships (Supplementary Fig. 14). For mutations in
separate lineages, both SCITE and B-SCITE perform well in
correctly detecting the correct separations, while OncoNEM has a
somewhat lower accuracy (Supplementary Fig. 15).
The effect of allelic dropout on the phylogenetic inference is
again relatively mild on B-SCITE compared with SCITE and
OncoNEM, while false positives play a more important role
(Supplementary Figs. 16, 17) and reduce the accuracy of all tools
by a small amount.
Performance in the presence of CNA events. Copy-number
aberrations (CNAs) perturb the fraction of mutated reads in the
affected regions, thereby shifting the observed VAFs. While the
model underlying B-SCITE expects mutations to come from
copy-number-neutral regions, it is not always possible to identify
and discard all other mutations. VAFs from copy-number-altered
regions are known to confound tree reconstruction and mutation
ordering from bulk data only. By also utilising single-cell data, B-
SCITE is quite robust to these effects, with only a small average
decrease in the co-clustering accuracy, as the number of CNAs in
the simulated data increases (Supplementary Fig. 18). For very-
high-coverage data, where the bulk VAFs play a stronger role in
the phylogenetic reconstruction, the effect is correspondingly
more pronounced (Supplementary Fig. 19). For the other accu-
racy measures, we see the same pattern for the two coverage
levels (Supplementary Figs. 20–23).
Performance in the presence of ISA violations. In the tree
inference (Methods), we employ the inﬁnite-sites assumption
(ISA), which states that mutations only occur once in the phy-
logeny and persist in descendent cells. Violations of this
assumption however only have a very weak effect on the struc-
tural accuracy of the other mutations (Supplementary Fig. 24).
Multiple bulk samples. To assess B-SCITE’s performance in
settings where multiple bulk samples are available and to see
whether additional bulk samples render single-cell data redun-
dant, we simulated data with up to four bulk samples and com-
pared B-SCITE with the bulk-only method PhyloWGS18
(Supplementary Figs. 25–27). Expectedly, reconstruction quality
of both tools improves, as the number of bulk samples increases.
While B-SCITE generally outperforms PhyloWGS, it is possible
to create settings that beneﬁt the bulk-only method, namely a
combination of high-quality and quantity bulk data with single-
cell data that badly reﬂects the tumour composition (small λ).
When looking at different settings for the bulk data, we observe
more accurate reconstruction with multiple bulk samples at lower
coverage as compared with a single bulk sample at high coverage.
Finally, for any ﬁxed number of bulk samples, we observe that the
reconstruction quality improves with the number of available
single cells.
Application to real data. To assess the performance of B-SCITE
on real tumour data, we analysed the sequencing data of two
patients with childhood leukaemia37, one triple-negative breast
cancer patient38 and two colorectal cancer patients with matched
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Fig. 4 Comparison of phylogenetic inference for OncoNEM, SCITE and B-SCITE for 100 simulated clonal trees with 10 nodes (clones) and 50 mutations.
For the single-cell data, we drew 25 genotypes from each clonal tree for various values of parameter λ, which controls bias in sampling single cells from
clones (large values of λ indicate a small bias, the where probability of drawing a single cell from a given clone is usually close to its prevalence in the entire
tumour cell population). We also added the following noise to the single-cell genotypes: false-positive rate 10−5, false-negative rate 0.2, missing (NA) rate
0.05 and doublet rates 0, 0.1 and 0.2. Bulk data coverage was set to 10,000, and variant read counts drawn from a binomial distribution. We obtained data
sets from trees for each parameter combination. A more detailed description of the simulation data and the deﬁnition of the co-clustering accuracy
measure are given in Supplementary Methods. Source data are provided as a Source Data ﬁle
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liver metastases39. Discussion of the results is provided below
and all details of data pre-processing can be found in Supple-
mentary Methods.
Acute lymphoblastic leukaemia (ALL). For both leukaemia
patients, a bulk sample was sequenced together with a large
number (>100) of single cells, for which targeted sequencing was
performed using a personalised panel. This allows us to compare
B-SCITE with methods relying solely on single-cell or bulk-
sequencing data. For our comparison, we chose CTPsingle20 for
the bulk-only approach and SCITE28 for single-cell-based
inference.
For patient 1, 20 mutations were detected sequencing one bulk
sample and 111 single cells. The phylogenies inferred by B-SCITE
and its two competitors are depicted in Fig. 5. CTPsingle, the
approach based on bulk samples, ﬁnds two trees compatible with
the observed frequencies. Both trees cluster the 20 mutations in
ﬁve subclones and are either completely linear or have a single
mutation in a separate branch. Using the SCS data of the same
patient, SCITE detects an early branching event that splits up
some of the subclones inferred by CTPsingle. Without knowledge
of the ground truth tree, there is no certainty whether the
branching reﬂects the true phylogeny. However, having data from
such a large number of cells and the close location to the root,
makes it highly likely that the branching is genuine. The same
branching is also inferred by B-SCITE, which ﬁnds generally the
same topology as SCITE, but arranges mutations differently in
linear segments of the tree. As expected, having the additional
information of VAFs for the individual mutations allows
B-SCITE to ﬁnd an ordering that is in better congruence with
the observed mutation frequencies, which should be in decreasing
order. As a consequence, the mutation ordering inferred by
B-SCITE is also closer to the subclone clustering of CTPsingle, in
the sense that mutations from the same cluster that are in the
same branch tend to be closer together than in the SCITE tree.
For this data set, we estimate the relative weight of the bulk data
to be 0.81 times that of the single-cell information.
For patient 2, 16 mutations were detected sequencing one bulk
sample and 115 single cells. CTPsingle reports a subclone
clustering that is compatible with many phylogenies and some
of them are depicted in Fig. 6a and Supplementary Fig. 28. SCITE
and B-SCITE each infer a single tree (Fig. 6b, c). The general
topologies of the two trees are again similar with different
arrangement of mutations on linear segments. In particular,
B-SCITE puts the mutations in FAM105A and CMTM8
higher up in their branch, which better reﬂects their relatively
high frequencies (44% and 42%). Notably, B-SCITE does not
completely sort the mutations in this branch by frequency, as
the mutation in RRP8 is placed between two mutations with
higher frequencies. This indicates that a strong signal for this
placement is coming from the single-cell data. Apart from issues
with mutation calling, a possible explanation could be a copy-
number change affecting RRP8, which decreases its observed
VAF. The bulk data play a stronger role for these data, with their
estimated weight to be 1.55 times that of the single cell.
Triple-negative breast cancer (TNBC). For the triple-negative
breast cancer patient, in the original study38, copy-number pro-
ﬁling of 50 single cells was ﬁrst performed. Next, 16 single
tumour cells were whole-exome sequenced and hierarchical
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Fig. 5 Mutation histories inferred from the bulk and single-cell sequencing data for a patient with childhood ALL (Patient 1 of the study in ref. 37): a Clonal
trees compatible with the bulk-sequencing data (inferred with CTPsingle20). Clones are annotated with the mean VAF of the mutations newly acquired by
the clone. bMutation tree inferred with SCITE28 from the single-cell panel sequencing data of 111 cells. The colouring scheme follows from the clustering in
the CTPsingle trees. Mutations are annotated with the VAFs observed in the bulk sample. cMutation tree inferred with B-SCITE from the combined single-
cell and bulk data. B-SCITE infers the same early branching event as SCITE, but ﬁnds a mutation ordering that is in better congruence with the bulk VAFs. B-
SCITE mutation trees can be compressed to clonal trees (Supplementary Fig. 29)
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clustering of the cells was performed based on proﬁles of a large
number (>500) of detected somatic SNVs, each present in more
than one of the 16 cells (mutations detected in only one cell were
discarded). A clonal tree was then manually reconstructed
(Extended Data Fig. 6b in ref. 38). Based on this tree, we provide a
clonal tree for the 18 mutations selected in Fig. 7a. For each of
these 18 mutations, the original study obtained bulk data read
counts from targeted ultra-deep sequencing, with an approximate
depth of coverage > 1,00,000×. Hence, we were able to run both,
SCITE and B-SCITE, on this data set as well. Trees obtained by
these tools are shown in Fig. 7b, c. Notably, B-SCITE infers a
mutation tree, which is in a strong concordance with the
clonal tree, and at the same time, in agreement with the variant
allele frequencies obtained from bulk data. On the other hand, the
tree inferred by SCITE has several differences compared with the
clonal tree, including the placement of the mutation in gene
SYNE2 on a different branch than the PPP2R1A and AURKA
mutations. Similarly, mutations reported to be clonal in ref. 38,
namely mutations in genes MAP2K7 and NTRK1, are placed on
different branches in the SCITE tree, and the placement of the
branch containing mutations in genes CHRM5 and TGFB2 is
closer to the root. In this tree, there are also several incon-
sistencies with variant allele frequencies of mutations obtained
from bulk data. With the high bulk coverage and the limited
number of single cells, the bulk data have a much higher relative
weight (≈2800 times) than the single-cell data. However, this does
not mean that the latter have no effect on the tree structure. In
fact, the bulk data favour a completely linear tree topology.
Colorectal cancer. We reanalysed the bulk and single-cell
sequencing data of two cases of colorectal cancer with liver
metastases39. The interesting feature of these data sets is the
availability of two bulk samples (primary tumour and metastasis)
in addition to single-cell data. Unfortunately, the original study
revealed in both patients the presence of aneuploid populations
at both sites via ﬂow sorting, which is not ideal for the use of
B-SCITE due to CNA-based shifts of bulk VAFs.
In the study, ﬂow-sorted cells were pooled and exome
sequenced en bulk. We obtained the read counts from these
experiments by processing the raw data from the SRA and used
them as bulk data input. The original study also comprised
targeted single-cell sequencing based on the T1000 cancer gene
panel (mean depth 137× at average coverage of 0.92). To run B-
SCITE, we focused on the mutations detected via single-cell
panel sequencing, but discarded mutations with insufﬁcient
coverage in the bulk samples. In addition, we removed cells
where no mutations were detected. These ﬁltering steps left 12
mutations and 72 single cells for CRC1 (CO5), and 25 mutations
and 86 single cells for CRC2 (CO8). The trees inferred by
B-SCITE are displayed in Fig. 8.
For CO5, we observe an almost linear tree structure. For the
primary tumour sample, VAFs are roughly decreasing, while we
observe a bigger ﬂuctuation for the metastasis sample. This may
be a direct consequence of the higher aneuploidy observed in the
liver metastatis compared with the primary site39. Compared with
the targeted sequencing of the previous case, bulk-sequencing
depth is relatively low here (with an average coverage depth of
69.25×). This is also reﬂected in a lower relative weight for the
bulk data (≈1.75).
For CO8, we observe a more branched structure. Notably,
there are two completely separate lineages, one of which is
only detected in the single-cell data. In the other branch, early
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Fig. 6 Mutation histories inferred from bulk and single-cell sequencing data for a patient with childhood ALL (Patient 2 of the study in ref. 37): a one of the
multiple clonal trees compatible with the bulk-sequencing data (inferred with CTPsingle20). Clones are annotated with the mean VAF of the mutations
newly acquired by the clone. Several other compatible trees are depicted in Supplementary Fig. 28. b Mutation tree inferred with SCITE28 from single-cell
panel sequencing data of 115 cells. The colouring scheme follows from the clustering in the CTPsingle tree. Mutations are annotated with the VAFs
observed in the bulk sample. c Mutation tree inferred with B-SCITE from the combined single-cell and bulk data. B-SCITE mutation trees can be
compressed to clonal trees (Supplementary Fig. 29)
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mutations all have VAFs >50%, indicating the presence of CNAs.
Fluctuation in VAFs in this tree part may indicate complex copy-
number events, but at the given sequencing depth (average of
105.76×) may also be attributed to read count variance. The
relative weight on the bulk data is 2.96 compared with the single-
cell data.
The lower branches are generally in good agreement with
decreasing bulk VAFs and show a clear distinction between the
primary and metastatic sample. Interestingly, the original study
reported two separate metastatic seeding events based on a tree
topology inferred from single-cell data alone39. In particular,
it places FUS (VAF 29.1% in the metastasis sample) in the second
metastatic lineage, while other mutations with similar VAFs in
the metastasis sample (LAMB4 27.6%, F8 30.0% and SPEN 25.1%)
are placed in the ﬁrst metastatic branch. This separation strongly
violates the ‘sum rule’ for bulk VAFs and is likely the reason why
B-SCITE chooses a topology which places these mutations into
a single lineage. To better understand this discrepancy, we
checked the single-cell genotype matrices inferred in the original
study (Supplementary Fig. 7)39 and found that the separate
placement of FUS requires that FUS mutation calls are explained
away as false positives in ten metastatic cells (MA_44, MA_42,
MA_41, MA_48, MA_29, MA_45, MA_90, MA_91, MA_33 and
MA_35). Another ambiguous mutation is ATP7B (3.1% metas-
tasis VAF), which the single-cell tree places above the metastatic
mutation FUS, while B-SCITE places it in the primary branch.
While in better congruence with the bulk data, the placement
chosen by B-SCITE comes at the cost of an increased number of
false-positive calls for ATP7B.
In general, there appears to be no tree topology that jointly
explains all aspects of the single-cell data, let alone both data
types. A possible explanation could be the presence of complex
events that are not covered by our tree model, such as mutation
loss or recurrent mutations. The absence of a well-ﬁtting tree
topology leads to two unwanted effects, both of which we observe
in this data set. First, the inferred tree topology can be strongly
inﬂuenced by the mutation choice. In the present data, lowering
the read count cut-off (to 5 instead of 20) and thereby discarding
fewer mutations is sufﬁcient to drive FUS into a separate
metastatic branch. Second, for a ﬁxed set of mutations, lower
branches in the tree can become unstable in the sense that
multiple branching variations obtain highly similar scores.
Having such a ‘ﬂat landscape' in high-scoring parts of the tree
search space makes it difﬁcult to ﬁnd a globally optimal tree. This
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Fig. 7 Mutation histories inferred from bulk (targeted sequencing with the average depth of coverage ∼100,000×) and single-cell (16 cells) data for a
patient with triple-negative breast cancer from ref. 38: a clonal tree implied by hierarchical clustering from the original study38. Clustering was performed
based on the proﬁles of several hundreds of mutations and four populations of cancerous cells were detected. In the same study, a subset of mutations was
selected from each cell population and each of them is listed in the label of the corresponding population. b Mutation tree inferred with SCITE28. The
colouring scheme follows the colouring used in the clonal tree. Mutations are annotated with the VAFs observed in the bulk sample. c Mutation tree
inferred with B-SCITE from the combined single-cell and bulk data. B-SCITE infers highly similar branchings as in the clonal tree and also ﬁnds a mutation
ordering that is in congruence with the bulk VAFs. B-SCITE mutation trees can be compressed to clonal trees (Supplementary Fig. 29)
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matches our observation that this data set took much longer
MCMC chains to consistently ﬁnd the best tree than normally
expected for data sets of this size.
Discussion
Recent advances in sequencing technologies allow large-scale bulk
and single-cell sequencing of tumour samples. The resulting data
are invaluable for understanding the evolutionary history and
subclonal composition of individual tumours and addressing
the issue of treatment failure due to resistant cell populations.
The bottleneck to fully leveraging the joint strength of both data
types is the lack of specialised software which integrates single-
cell and bulk-sequencing data in a joint inference scheme. Prior to
this work, only a single tool (ddClone) has been available, where
subclone inference based on bulk-sequencing data is informed by
single-cell genotypes, but no integrative tool has been published
for phylogeny inference. To ﬁll this gap, we have developed B-
SCITE, the ﬁrst approach for inferring tumour phylogenies
and subclonal compositions from combined single-cell and bulk-
sequencing data. B-SCITE uses a joint likelihood model to inte-
grate both data types and performs a probabilistic search to ﬁnd
the best combination of a fully resolved mutation history and
values for the model parameters. Extensive simulation studies
show that B-SCITE systematically outperforms competing single-
cell-based approaches, thereby indicating that bulk data make
a valuable contribution to the inference. The quantity of the
performance gain depends on the degree of sampling distortion
between the single-cell samples and the composition of the
bulk tumour. However, even in cases where the single-cell data
very well reﬂect the tumour composition, B-SCITE outperforms
its competitors.
Since the identiﬁcation of the correct copy-number states of
mutated sites can be a challenge, we performed additional tests
with bulk VAFs that one could expect to arise from non-diploid
regions. While B-SCITE is designed and works best for hetero-
zygous mutations at copy-number-neutral sites, it still shows a
robust performance when a subset of the mutation sites is affected
by CNAs.
To compare B-SCITE with ddClone, the only other tool
combining single-cell and bulk-sequencing data, we obtained
subclones from B-SCITE’s fully resolved mutation histories by
performing a local mutation clustering. Experiments on a com-
prehensive set of simulated data sets showed that B-SCITE sys-
tematically outperforms ddClone, suggesting that subclone
inference beneﬁts from taking the underlying phylogeny into
account.
In addition, we explored the usefulness of combining bulk
and single-cell data in the analysis of real tumours. Looking at the
data from two patients with childhood leukaemia from ref. 37,
where a large number (>100) of single cells were sequenced,
we ﬁnd that B-SCITE and the single-cell-only approach SCITE
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Fig. 8 B-SCITE mutation histories for two cases of colorectal cancer with liver metastases39. a CRC1 (CO5) and (b) CRC2 (CO8). Mutations are annotated
with the VAFs of the two bulk samples (left: primary tumour, right: liver metastasis). Bulk data come from whole-exome sequencing (at 75.5× depth and
97.33% coverage) of pooled ﬂow-sorted single cells (for aneuploidy detection). Single-cell data come from targeted panel sequencing (T1000 cancer gene
panel) at mean depth 137× with an average coverage of 0.92. B-SCITE was run on mutations detected in the panel sequencing that had a minimum read
depth of 20 in the bulk samples. Cells without any of the remaining mutations were discarded for being non-informative in the tree inference. These
ﬁltering steps left 12 mutations and 72 single cells for CRC1 (CO5), and 25 mutations and 86 single cells for CRC2 (CO8). Fluctuating VAFs are likely due
to a combination of CNAs and artefacts from limited sequencing depth in the whole-exome sequencing data. Note that in CRC2, APC and SPEN have each
two independent point mutations denoted as (APC_1, APC_2, SPEN_1 and SPEN_2)
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infer very similar branchings in the tumour phylogenies, while B-
SCITE shows an improved ability in reconciling the temporal
ordering of mutations with their VAFs. In cases where B-SCITE
refrains from ordering mutations by decreasing VAFs, we suspect
the presence of a copy-number change, whose signal was over-
ridden by a strong contrary signal in the single-cell data. This
gives further evidence that B-SCITE is to some extent robust to
data deviating from the assumption that all mutations are het-
erozygous and at copy-number-neutral sites.
We also tested B-SCITE on a triple-negative breast cancer
patient from ref. 38, from which 16 single cells were sequenced.
In contrast to SCITE, B-SCITE infers a tree, which is in high
concordance with the expert-generated tree for the 18 mutations
pre-selected in the original study. These results suggest potential
advantage of using B-SCITE over the existing methods in clinical
settings, where a targeted subset of cancer-relevant genes are
sequenced.
Methods
Tree models of tumour evolution. A clonal tree T, depicting subclonal tumour
evolution in a cancer patient with a set of detected somatic mutations M= {M1,
M2,…, Mn}, is a labelled rooted tree with node set V(T)= {v1, v2,…, vs, vs+1}. Its
root vs+1 represents the population of healthy cells of the patient, and the other
nodes represent s tumour subclonal populations (subclones) of the same individual,
which are all genetically different. The mutational label associated with a node vi,
denoted as LT(vi), is a subset of M and represents the set of mutations acquired
at subclone vi. In other words, for each non-root node vi, LT(vi) represents the set
of all mutations present at subclone vi, but absent from subclone vj, where vj is
parent of vi in T. We assume that the population of healthy cells does not harbour
any mutation and therefore set LT(vs+1)=∅. As subclones are all genetically dif-
ferent, we have that LT(v) ≠∅ for each v∈ {v1, … vs}. Furthermore, assuming that
we have h different bulk samples of the analysed tumour, we also add a frequency
label to each node vi∈ V(T). The frequency label of node vi is represented as a
vector (ϕi1, ϕi2,…, ϕih), where ϕij denotes the relative frequency of cell population vi
in bulk sample j.
In this work, we assume that each mutation was acquired exactly once by one
subclone and then passed on to all its descendants (inﬁnite-sites assumption).
Consequently, LT(vi) ∩ LT(vj)=∅ for all pairs (vi,vj) (mutations are acquired only
once) and
Ss
i¼1 LT við Þ ¼ M (each of the observed mutations emerged in some of
the subclones). As we assume that mutations are never lost, the set of mutations
present in a subclone vi consists of all mutations acquired along the path from the
root to vi.
The topology of clonal tree T can be represented by an s × s ancestor matrix AT
deﬁned as follows (we assume 1-based indexing of matrix entries):
AT ½i; j ¼
1; if vi is an ancestor of vj inT; or i ¼ j
0; otherwise:

ð1Þ
Below, we also allow the use of AT[vi, vj], which is deﬁned to be equal to AT[i, j].
For convenience of notation, we also introduce function NT:M→V(T) with
NT(Mi) deﬁned as the node of the ﬁrst occurrence of mutation Mi in clonal tree T.
In other words, NT(Mi) = vj if and only if Mi ∈ LT(vj).
For tree inference based on single-cell data, the mutation tree model that
does not cluster mutations into subclones is more natural. The mutation tree can
be deﬁned as a special case of a clonal tree where s= n. This obviously implies
that |LT(vi)|= 1 for each non-root node vi from V(T). Furthermore, for each such
node and without loss of generality, we may assume that LT(vi) = Mi.
Input data. We assume that a set M= {M1, M2,…, Mn} of heterozygous somatic
single-nucleotide variants from diploid regions of the genome is given. These
mutations were observed in a tumour via sequencing of h bulk samplesℬ1,ℬ2,…,
ℬh, and m single-cell samples C1; C2; ¼ ; Cm .
For each mutation Mi and each bulk sample ℬj, the bulk sequencing provided
the number of variant and total reads spanning the genomic position of Mi in Bj ,
denoted, respectively, by rij and tij. SCS provided the observed mutation proﬁles of
cells C1; C2; ¼ ; Cm as the column vectors of a mutation matrix Dn×m deﬁned as
D½i; j ¼
0;
1;
NA;
if Mi is reported to be absent from Cj
if Mi is reported to be present in Cj
if status of Mi in Cj is not known ðmissing entryÞ:
8><
>: ð2Þ
Tree scoring based on bulk-sequencing data. Assume that we are given a
mutation tree T over n= s mutations, whose (s+ 1) nodes represent the set of
cellular subpopulations in the analysed tumour. For each bulk sample ℬj, our
goal is to assign non-negative real values Φj = {ϕ1j, ϕ2j,…, ϕ(s+1)j} to the nodes
of T such that
ϕ1j þ ϕ2j þ ¼ þ ϕ sþ1ð Þj ¼ 1 ð3Þ
and the likelihood of bulk-sequencing data (deﬁned below) be maximised. Intuitively,
ϕij represents the inferred fraction of the cellular population vi in the sample ℬj.
Consider an arbitrary mutation Mi. By the assumption made above, Mi occurs
for the ﬁrst time at node vi and is present at vi and all of its descendants (i.e., nodes
vj such that AT[i, j] = 1). This implies that the inferred fraction yij of cells
harbouring mutation Mi in sample ℬj is given by the formula
yij ¼
Xs
l¼1
AT ½i; l  φlj: ð4Þ
Alongside the tree constraints in Eqs. (3) and (4), we introduce a likelihood
model for the bulk-sequencing data to allow us to combine it with the single-cell
measurements.
Consider a genomic position P in a diploid genome region that has a (sub-)
clonal heterozygous mutation M ∈ M in a tumour. Let y be the fraction of cells
harbouring M in an arbitrary bulk sample. Assume that we sequence this bulk
sample and obtain a total of t reads that span P, of which r supports the variant M.
Based on the composition of the considered bulk sample, the probability that a read
supports M is y2 (since M is heterozygous and from a diploid region). We assume
that the sampled number of variant reads r follows a binomial distribution with
parameters t (number of trials) and y2 (success probability). For high-coverage t, the
binomial distribution can be approximated by the Gaussian distribution with mean
μ ¼ t  y2 and standard deviation σ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
t  y2  1 y2
 q
. The logarithm of the
probability density is
log
1ﬃﬃﬃﬃﬃ
2π
p þ log 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
t  y2  1 y2
 q  t8  y2  1 y2   z  yð Þ
2
ð5Þ
where z ¼ 2rt , which represents the bulk-sequencing data-based fraction of cells
harbouring mutation M, based on the assumption that M is from a diploid region.
Full details of derivation of Eq. (5) are provided in the Supplementary Methods.
For a given assignment of values yij, after discarding constant terms, the log-
likelihood of the entire bulk data is then
Xn
i¼1
Xh
j¼1
log
1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
tij  yij2  1
yij
2
 q  tij8  yij2  1 yij2   zij  yij
 2264
3
75: ð6Þ
Our goal is to maximise the likelihood over the latent variables yij, under the
constraints Eqs. (3) and (4) imposed by the tree topology. To make this
maximisation problem tractable by existing solvers, we use bulk data-derived
frequencies zij ¼ 2rijtij to approximate the standard deviations
σ ij ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
tij 
yij
2
 1 yij
2
 r

ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
tij 
zij
2
 1 zij
2
 	s
so that the log terms in Eq. (6) become constant and can be removed from the
optimisation, while quadratic term coefﬁcients become constants. Our problem
then transforms to maximising the likelihood over the underlying frequencies.
We therefore deﬁne the score of the bulk data to be
Sbulk Tð Þ ¼ maxy11 ;y12 ;¼ ;yðsþ1Þh
Xn
i¼1
Xh
j¼1
tij
8  zij2  1
zij
2
   zij  yij 2;
subject to the restrictions imposed in Eq. (3) and Eq. (4), where the sum involves
the weighted quadratic terms from the Gaussian approximation. Obtaining the
optimal values for yij represents an instance of a Quadratic Program (QP), which
is readily solvable by the existing commercial and free QP solvers. For our
purposes, we have used IBM ILOG CPLEX Optimization Studio V12.5.
Tree scoring based on single-cell data. For the tree scoring based on single-cell
data, we need to assess how well the observed mutation states of the single cells
match the subclones deﬁned by T. Due to noise in the mutation matrix D, the
single cells will likely ﬁt to none of the s + 1 cell populations deﬁned by T perfectly,
even if the tree represents the true mutation history of the tumour. We account
for this by using the probabilistic error model introduced in ref. 28: let the
vector σ = (σ1, σ2,…, σm) deﬁne the attachments of the single cells to T, such
that cj, the single cell corresponding to column j in D, attaches to vσj . Then we
expect cj to have the mutations assigned to the nodes vi that belong to the path
from root to vσj (i.e., all nodes vi such that AT[i, σj] = 1). The observational
probabilities are then
PðD½i; j ¼ 1jAT ½i; σj ¼ 0Þ ¼ α
PðD½i; j ¼ 0jAT ½i; σj ¼ 0Þ ¼ 1 α
PðD½i; j ¼ 0jAT ½i; σj ¼ 1Þ ¼ β
PðD½i; j ¼ 1jAT ½i; σj ¼ 1Þ ¼ 1 β;
ð7Þ
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where α denotes the probability of observing a false positive and β denotes the
probability of observing a false negative. The two error rates are summarised as θ =
(α, β) in the following. By setting the probability of having missing observations (D
[i, j] = NA) to 1 independent of the true state, they are neutral and do not
contribute to the tree scoring
PðD½i; j ¼ NAjAT ½i; σj ¼ 0Þ ¼ 1
PðD½i; j ¼ NAjAT ½i; σj ¼ 1Þ ¼ 1:
ð8Þ
Assuming that the observational errors are independent of each other, the
likelihood of a given mutation tree T, sample attachment vector σ and θ is then
P DjT; θ; σð Þ ¼
Yn
i¼1
Ym
j¼1
P D½i; jjAT ½i; σj
 
: ð9Þ
In the following, we marginalise out the sample attachments to focus on the
mutation tree as the informative part of the mutation history, which is also more
robust against noise than the location of individual samples in the tree. This gives
us
P DjT; θð Þ ¼
X
σ
P DjT; θ; σð ÞP T; θ; σð Þ: ð10Þ
In practice, SCS data are often contaminated with doublet samples. Therefore,
we treat each sample as a weighted mixture of a singlet and doublet sample27. The
marginalised likelihood then becomes
P0 DjT; θð Þ ¼ max
0δ1
Qm
j¼1
ð1 δÞP
σj
PðDjjT; θ; σjÞPðσjjT; θÞ
"(
þ δP
σj
P
σ′j
PðDjjT; θ; σj; σ′jÞPðσj; σ′j jT; θÞ
3
5
9=
;
ð11Þ
where δ is the probability of a sample being a doublet and Dj is the jth column of D,
which represents the observed mutation states of cell j. The double sum over the
attachment points σj and σj' creates all combinations of attachment pairs. This can
be efﬁciently computed in time O(mn2)27. Finally to obtain a single-cell-based tree
score that is on a comparable scale to the bulk score, we take the log of the
marginalised likelihood
SscðT; θÞ ¼ logðP0ðDjT; θÞÞ:
Combined B-SCITE approach. To measure how well a candidate mutation tree T
ﬁts a combination of bulk and single-cell measurements, we use the joint log-
likelihood score deﬁned as
Sjoint T; θð Þ ¼ Sbulk Tð Þ þ Ssc T; θð Þ:
Our goal is to ﬁnd a combination (T,θ)* that maximises the above score:
ðT; θÞ ¼ argmax
ðT;θÞ
SjointðT; θÞ:
The number of possible mutation trees is too large to allow for an exhaustive
search. Therefore, we use the Markov chain Monte Carlo approach introduced
in ref. 28 to search the joint (T, θ) space. In each step, it proposes a new state,
which has either a new mutation tree T′ or a new parameter θ'. The proposal
probability q(T′, θ'|T, θ) is determined by the neighbourhood size of the respective
move type. A new tree T′ is obtained from T by (i) pruning and re-attaching of a
subtree, by (ii) swapping two subtrees or by (iii) the exchange of the labels of two
nodes (see ref. 28 for more details). The key difference to SCITE is that the
probability of accepting a new state is now depending not only on the observed
single-cell mutation proﬁles but also on the bulk VAFs. Hence, the acceptance
probability becomes
min 1;
q T; θjT 0; θ0ð Þ  eSjoint T 0 ;θ0ð Þ
qðT 0; θ0 jT; θÞ  eSjoint T;θð Þ
( )
:
Note that Sbulk(T) does not depend on θ. Therefore, it needs not to be
recomputed to obtain Sjoint(T, θ′) after a θ-move.
Compression of mutation trees into clonal trees. To compare the mutation tree
T inferred by B-SCITE with clonal trees inferred in OncoNEM or mutational
clusters inferred in ddClone, we ﬁrst perform clustering of mutations in T in
order to identify clones. Mutations placed on different branches in T are
expected to evolve in divergent clones; hence, we assume that they are not
clustered together into the same clone. Furthermore, each of the branching
nodes of T (i.e., nodes having more than one child) represent the emergence of
new clonal populations in the subtrees formed by its descendants. This moti-
vated us to ﬁrst identify all linear chains in T, which do not contain any
branching node (except for the end nodes). Then, for each such chain, we
discard its end node closest to the root and cluster the remaining mutations
along the linear chain.
For the clustering, we employ a 1D Gaussian mixture model for the cellular
frequencies yi of the mutations in the chain. The standard deviation of each
component is ﬁxed by its mean through the binomial approximation according
to Eq. (5). Therefore, only the mean of each component and the assignment of
mutations to components need to be inferred, for which we employ the EM
algorithm. The optimal number of mixture components is selected according to the
Akaike information criterion.
As clustering is performed based on the inferred mutation frequencies, which
decrease down the chain, only subsets of consecutive mutations can get clustered
together. For each cluster of the mutations obtained in the clustering step, we
merge their corresponding nodes into a single node and assign all mutations from
the cluster to this node. The whole procedure results in the clonal tree of tumour
evolution.
With multiple bulk samples, the mixture components and the assignment of
mutations to them is shared across the samples, and we simply allow each
component to have a different mean for each sample.
Estimating the relative contribution of bulk and SCS data. To estimate the
range of the single-cell and bulk-based scores, we deﬁne a baseline tree, T^ , with a
single clone containing all mutations, which are then present in all single cells. The
range of the log scores of each data type is then
SbulkðTÞ  SbulkðT^Þ and SscðTÞ  SscðT^Þ
allowing us to deﬁne an estimate of the relative weight of the bulk data to the single
cell as
ρ ¼ SbulkðT
Þ  SbulkðT^Þ
SscðTÞ  SscðT^Þ
:
This estimate can inform the weighting parameter ω to balance the two data
types:
ω ¼ ρ
1þ ρ :
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The human sequencing data sets utilised in this study are available for download from
the Sequence Read Archive with the accession numbers: SRP044380 (for ALL patients),
SRA053195 (for TNBC patients) and SRP074289 (for CRC patients).
Code availability
B-SCITE has been implemented in C++ and is freely available under a GNU General
Public License v3.0 at https://github.com/smalikic/B-SCITE.
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